Corient Private Wealth
ELAN icon

Corient Private Wealth’s Elanco Animal Health ELAN Stock Holding History

Corient Private Wealth’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6M Sell
152,731
-113,545
-43% -$2.78M 0.01% 971
2025
Q4 		$4.56M Buy
266,276
+191,888
+258% +$4.18M ﹤0.01% 1093
2025
Q3 		$1.5M Buy
74,388
+9,240
+14% +$155K ﹤0.01% 1211
2025
Q2 		$930K Buy
65,148
+27,772
+74% +$325K ﹤0.01% 1392
2025
Q1 		$392K Sell
37,376
-4,945
-12% -$55.9K ﹤0.01% 1721
2024
Q4 		$513K Sell
42,321
-1,057
-2% -$13.8K ﹤0.01% 1602
2024
Q3 		$637K Buy
43,378
+3,319
+8% +$46.2K ﹤0.01% 1611
2024
Q2 		$578K Sell
40,059
-1,083
-3% -$17.3K ﹤0.01% 1569
2024
Q1 		$670K Buy
41,142
+171
+0.4% +$2.67K ﹤0.01% 1485
2023
Q4 		$610K Sell
40,971
-1,249
-3% -$14.1K ﹤0.01% 1508
2023
Q3 		$475K Buy
42,220
+7,845
+23% +$91.1K ﹤0.01% 1523
2023
Q2 		$346K Buy
34,375
+23,248
+209% +$216K ﹤0.01% 1630
2023
Q1 		$105K Buy
+11,127
New +$131K ﹤0.01% 1877

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Corient Private Wealth's ELAN Position: Q1 2026 in Review

Corient Private Wealth reduced its Elanco Animal Health (ELAN) stake by 43% in Q1 2026, selling an estimated $2.78M and leaving 152,731 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #971.

Corient Private Wealth first reported a position in ELAN in Q1 2023 and has held it in 13 quarters since. The position peaked at $4.56M in Q4 2025. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Corient Private Wealth held 152,731 shares of Elanco Animal Health worth $3.6M as of Q1 2026.
  • Corient Private Wealth sold 113,545 Elanco Animal Health shares in Q1 2026, an estimated $2.78M.
  • Elanco Animal Health made up 0.01% of Corient Private Wealth's portfolio in Q1 2026, its #971 holding.
  • Corient Private Wealth first reported a position in Elanco Animal Health in Q1 2023 and has held it in 13 quarters since.
  • Corient Private Wealth's Elanco Animal Health position peaked at $4.56M in Q4 2025.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.